Subscribe to RSS
DOI: 10.1055/s-0030-1258769
Improved Synthetic Route to C-Ring Ester-Functionalized Prodigiosenes
Publication History
Publication Date:
30 September 2010 (online)
Abstract
An efficient, optimized, and scalable process for the synthesis of C-ring ester-functionalized prodigiosenes has been developed by (i) exploiting a silylative Mukaiyama aldol strategy for the condensation of alkyl 5-formyl-2,4-dimethylpyrrole-3-carboxylate and 4-methoxy-3-pyrrolin-2-one to form the corresponding ester-functionalized dipyrrinone analogues, and (ii) developing a facile synthesis of stable bromodipyrrin analogues for the use in formal Suzuki coupling reactions. The process was applied to the synthesis of three C-ring ester-functionalized prodigiosenes in multigram scales (up to 6.5 g prodigiosene free-base) with useful yields (35-56% overall yields over three steps starting from the 2-formyl pyrroles).
Key words
prodigiosin - prodigiosene - bromodipyrrin - dipyrrinone - bromination
Prodigiosenes belong to a family of tripyrrolic red pigments with important biological properties. [¹] Thus several investigations have been focused on the structure-activity relationships in prodigiosenes. [²] Recently, we have discovered that C-ring functionalized prodigiosenes exhibit efficient anticancer properties in effective doses. [³] [4] These discoveries stimulated the development of an expedient synthetic strategy to prepare novel analogues with potent anticancer properties (Figure [¹] ) and to prepare highly active derivatives on a multigram scale.

Figure 1 C-Ring ester-functionalized prodigiosenes
Two main synthetic strategies for the synthesis of the tripyrrolic skeleton of prodigiosenes have been reported: (i) the condensation of a bipyrrole unit with the C-ring moiety (path A and path B, Scheme [¹] ), [5] [6] and (ii) the coupling of a dipyrrin unit with the A-ring (path C, Scheme [¹] ). [7]
Path A suffered from low yields as the bipyrrolic unit was consistently synthesized using a low yielding McFayen-Stevens reduction. [5] An alternative strategy to generate the bipyrrolic unit was recently developed by Dairi et al. (path B, Scheme [¹] ) and involves the synthesis of a 2-formyl bipyrrole in a two-step route from 4-methoxy-3-pyrrolin-2-one. [8] [9] Unfortunately, this process was not successful in our hands as the 2-formyl bipyrrole could only be isolated in low and irreproducible yields.
Path C is relatively more convenient and has traditionally relied on a base-promoted condensation of a 2-formyl pyrrole with a pyrrolin-2-one to generate the dipyrrinone unit, followed by formation of the triflated analogues and then Suzuki coupling to the final pyrrolyl-dipyrrin skeletons. [³] However, the base-promoted condensation step of this process to generate the dipyrrinones suffers serious limitations due to the equilibrium between the retro 2-formyl pyrrole in the presence of strong base, as observed by others during the synthesis of metacycloprodigiosin. [¹0] Once synthesized, the dipyrrinone is converted into a triflate analogue, which, depending on the substituent at R¹, has limited thermal stability. The low thermal stability of these analogues renders purification of multigram quantities problematic.
As part of our studies towards mapping the SAR profile of C-ring ester-functionalized prodigiosenes with optimized immunosuppressive properties, we needed an improved synthetic process with (i) a short reaction sequence, (ii) an alternative condensation step to form the dipyrrinone unit, and (iii) a stable analogue for use in the formal Suzuki diheteroaryl coupling reactions with BOC-protected pyrrole 2-boronic acid. We anticipate that addressing these issues would result in a scalable synthetic process. Our investigations in this regard are discussed herein.
Our synthetic strategy (Scheme [²] ) involved starting with 2-formyl pyrroles 4, synthesized by following a slight modification of a reported protocol. [¹¹] Knorr pyrrole 5-tert-butyl esters 2a,b were subjected to acid-promoted hydrolysis, decarboxylation to give 3a,b, then Vilsmeier formylation to give 4a-c in almost quantitative overall yields (Scheme [²] ). Based on the understanding that the base-promoted condensation of 4a-c and 5 suffers several drawbacks due to a reversible retro 2-formyl pyrrole generation in the presence of a strong base, [¹0] we used an alternative strategy involving dual Lewis acid-Lewis base activation using a silylative Mukaiyama aldol strategy. [¹0] [¹²] Acid-promoted elimination of the OTMS functionality gave the dipyrrinone analogues 6a-c in moderate to good yields (Scheme [²] ).
The dipyrrinones 6a-c were observed to form as a mixture of distinguishable isomers I and II depending on the reaction conditions, that is, acid concentration and dilution. The structural assignment for the isomeric dipyrriones I and II was executed using NOESY (Figure [²] ). In the NOESY spectrum, the correlation between NH/NH of the major isomer I indicated the Z-configuration at the dipyrrin moiety, and the correlation between NH/meso-H of the minor isomer II indicated the E-configuration (Figure [²] ).

Scheme 1 Synthetic strategies for the synthesis of prodigiosenes

Scheme 2 Preparation of ester-functionalized dipyrrinone analogues. a 4c was prepared using an esterification strategy (see Supporting Information for more details).

Figure 2 NOESY correlations observed for the dipyrrinones I and II
The structure of the major isomer was further confirmed by the isolation of the major isomer in pure form by altering the reaction conditions. The structure of benzyl ester dipyrrinone 6b was confirmed by an X-ray crystal structure (Figure [³] ).

Figure 3 X-ray crystal structure of 6b
In our previous work with prodigiosenes, we noted that several triflate analogues were thermally unstable. [³] In one case, a symmetrical dipyrrin byproduct was isolated from the triflation reaction mixture. The generation of this symmetrical dipyrrin byproduct 8 [¹³] (Figure [4] ) is probably due to the hydrolysis of the dipyrrinone as its triflate in the presence of even trace amounts of moisture, followed by acid-catalyzed self-condensation.

Figure 4 The symmetrical dipyrrin byproduct 8
With the knowledge that triflate analogues had proven problematic, our modified strategy for the synthesis of C-ring ester-functionalized prodigiosenes focused on the analogous bromodipyrrin analogues 7a-c. Bromination of the dipyrrinone using POBr3 was thought to be a viable alternative based on the work of Dairi, [8] who used POBr3 to brominate pyrrolinones, and Rapoport, [¹4] who used POCl3 to chlorinate pyrrolinones.
Regardless of isomeric ratios, when the dipyrrinones 6a-c were treated with POBr3, isomers I and II react to generate a single isomer of the corresponding bromodipyrrins (Scheme [³] ). The bromodipyrrins were obtained as HBr salts, which, upon basic workup, gave free bases 7a-c in good yields (up to 85%). These meso-unsubstituted bromodipyrrins are stable at room temperature under air and can be used in bench-top operations, making them feasible intermediates for the large-scale production of prodigiosenes.
Finally, the Suzuki coupling reaction of bromodipyrrins 7a-c with N-Boc-protected pyrrole-2-boronic acid worked well as for the triflated analogues, and was used effectively for the large-scale synthesis of prodigiosenes 1a-c (up to 6.5 g prodigiosene free base) in good yields (35-56% overall yields over three steps starting from the 2-formyl pyrroles; Scheme [³] ).

Scheme 3 Preparation of ester-functionalized prodigiosenes
In addition, we investigated a convergent hydrolysis/esterification approach to a series of new prodigiosene esters using 1a [¹5] and 1b. Several attempts were made to hydrolyze the ethyl ester of 1a and, although the required crude carboxylic acid product was observed using mass spectrometry, it was unstable and could not be isolated. Hydrogenolysis of the benzyl-ester functional group of 1b followed by esterification of the crude acid reaction mixture was similarly unsuccessful, probably due to the low stability of the carboxylic acid. As another alternative method, direct transesterification of ethyl ester prodigiosene 1a was attempted. High-pressure microwave-promoted reaction conditions were used for the transesterification of ethyl ester prodigiosene 1a in attempts to generate the methyl ester 1c, the n-butyl ester 1d, and the 2-propyl ester prodigiosene 1e. The results of experiments towards these transformations are shown in Scheme [4] with the investigated conditions listed in Table [¹] .

Scheme 4 Microwave-promoted transesterification of prodigiosene 1a
R | Conditions | Results | |||||||||||||||||
Me | NaOMe (1.2 equiv), MeOH, 125 ˚C, 10 min | 1a and 1c | |||||||||||||||||
NaOMe (1.5 equiv), MeOH, 125 ˚C, 20 min | 1c 75-87% | ||||||||||||||||||
NaOMe (1.5 equiv), MeOH, reflux,a 20 min | 1a recovered | ||||||||||||||||||
n-Bu | NaOn-Bu (15 equiv), n-BuOH, 200 ˚C, 40 min | 1a and 1d | |||||||||||||||||
i-Pr | NaOi-Pr (125 equiv), i-PrOH, 140 ˚C, 40 min | 1a and 1e | |||||||||||||||||
| |||||||||||||||||||
a Without
using microwave. |
The ethyl ester prodigiosene 1a was successfully transesterified to give the methyl ester prodigiosene 1c, in high yields, by treating it with 1.5 equivalents of sodium methoxide and heating the reaction to 125 ˚C for 20 minutes in methanol under microwave irradiation. When the same reaction was carried out under reflux conditions, 1a was recovered quantitatively, thus identifying the microwave promotion to be key for the transesterification to be successful. When this method was adapted to n-butyl and 2-propyl alkoxides, ¹H NMR spectroscopic analysis showed the presence of the desired product along with remaining starting material, even though large excesses of the alkoxides were used. Re-subjection of these mixtures to the reaction conditions did not noticeably improve the ratio of starting material to product, and the mixtures of starting material and product could not be adequately separated using column chromatography. Although this method produced the methyl ester derivative 1c in good yield, it was not general for other esters and not a synthetically viable method for synthesizing prodigiosene C-ring esters.
In conclusion, we have developed an efficient method for the multigram synthesis of functionalized prodigiosenes using a silylative Mukaiyama aldol strategy to generate dipyrrinone intermediates and using stable bromodipyrrins in place of triflates in the final Suzuki coupling reaction to generate the prodigiosene targets. The process was successfully applied to the total synthesis of three C-ring ester-functionalized prodigiosenes.
General Procedures and Representative Data
Compounds 2a,b, [¹¹] 3a,b, [¹¹] 4a,b, [¹¹] 4c, [¹6] and 6a-c [¹0] [¹²] were prepared following modified literature procedures.
Procedure for the Synthesis of Bromodipyrrins
(7)
To a stirred suspension of 6a (3.4
g, 11.7 mmol) in dry CH2Cl2 (250 mL) was added
POBr3 (6.70 g, 23.37 mmol). The resulting solution was
heated at reflux temperature under nitrogen for 17 h. After the reaction
mixture was cooled to r.t., sat. NaHCO3 (500 mL) was
added at 0 ˚C, and the organic layer was separated,
washed with brine and H2O, dried using anhyd Na2SO4,
filtered, and the solvent was evaporated in vacuo. The crude product
was purified by passing a solution in EtOAc through a pad of silica
gel eluting with 20% hexane in EtOAc to give the title
compound 7a as bright orange yellow solid
(3.30 g, 80%).
¹H NMR (500
MHz, CDCl3): δ = 11.20 (1 H, br s),
6.94 (1 H, s), 5.59 (1 H, s), 4.29 (2 H, q, J = 7.0
Hz), 3.85 (3 H, s), 2.59 (3 H, s), 2.40 (3 H, s), 1.36 (3 H, t, J = 7.0 Hz). ¹³C
NMR (125 MHz, CDCl3): δ = 167.5, 165.4,
147.2, 144.1, 139.2, 134.1, 126.5, 115.9, 114.1, 100.2, 59.7, 58.7,
15.2, 14.6, 11.6. HRMS (ESI+): m/z calcd
for C15H18BrN2O3 [M+]:
353.0495; found: 353.0482.
Procedure for the Synthesis of Prodigiosenes
(1)
Compound 7a (3.20 g,
9.06 mmol), LiCl (1.16 g, 27.36 mmol), 1-N-Boc-pyrrole-2-boronic
acid (2.32 g, 10.99 mmol), and Pd(PPh3)4 (1.05
g, 0.91 mmol) were dissolved in 1,2-dimethoxyethane (180 mL), and
the solution was purged by bubbling with nitrogen for 10 min. A
solution of Na2CO3 (2 M, 18.2 mL, 36.4 mmol)
was then added, and the reaction mixture was stirred at 85 ˚C
for 24 h. After cooling to r.t. the reaction mixture was poured
into H2O. Extraction with EtOAc (3 × 100
mL), followed by washing of the combined organic fractions with
brine (150 mL), drying with anhyd Na2SO4, filtration,
and evaporation of the solvent in vacuo gave the crude product that
was purified using flash chromatography on neutral aluminum oxide
(grade III) using a gradient of EtOAc-hexane (10:90 to
20:80) as eluent to give the prodigiosene free base (2.73 g, 89%).
Then a solution of HCl in MeOH (0.75 M, 1.5 equiv) was added to
a solution of the free base in MeOH-CHCl3 (20:1)
to give 1a as deep pink solid.
¹H
NMR (500 MHz, CDCl3): δ = 12.90 (1
H, br s), 12.69 (1 H, br s), 12.64 (1 H, br s), 7.28 (1 H, s), 7.09
(1 H, s), 6.98 (1 H, s), 6.37 (1 H, s), 6.09 (1 H, s), 4.30 (2 H,
d, J = 7.0 Hz), 4.04 (3 H, s),
2.80 (3 H, s), 2.50 (3 H, s), 1.37 (3 H, t, J = 7.0
Hz). ¹³C NMR (125 MHz, CDCl3): δ = 166.7,
164.7, 150.4, 150.1, 140.6, 128.5, 123.5, 122.5, 122.1, 119.1, 115.9,
113.0, 112.5, 93.5, 60.1, 59.2, 14.9, 14.5, 12.0. UV/vis: λmax (CHCl3) = 528
(ε = 108017), 500 (ε = 51587).
HRMS (ESI+): m/z calcd
for C19H22N3O3 [M + H]+:
340.1656; found: 340.1637.
Supporting Information for this article is available online at http://www.thieme-connect.com.accesdistant.sorbonne-universite.fr/ejournals/toc/synlett.
- Supporting Information for this article is available online:
- Supporting Information
Acknowledgment
This work was supported by the Canadian Institutes for Health Research (CIHR) and the Canadian Breast Cancer Foundation-Atlantic Region. S.M.C. thanks the Natural Sciences and Engineering Research Council of Canada (NSERC) for a graduate scholarship. We offer our gratitude to Carlie Charlton for her help in this research.
- 1a
Baldino CM.Parr J.Wilson CJ.Ng S.Yohannes D.Wasserman HH. Bioorg. Med. Chem. Lett. 2006, 16: 701 - 1b
D’Alessio R.Bargiotti A.Carlini O.Colotta F.Ferrari M.Gnocchi P.Isetta A.Mongelli N.Motta P.Rossi A.Rossi M.Tibolla M.Vanotti E. J. Med. Chem. 2000, 43: 2557 - 1c
Davis JT.Gale PA.Okunola OA.Prados P.Iglesias-Sánchez JC.Torroba T.Quesada R. Nature Chem. 2009, 1: 138 - 1d
Diaz RIS.Regourd J.Santacroce PV.Davis JT.Jakeman DL.Thompson A. Chem. Commun. 2007, 2701 - 1e
Gerber NN. J. Antibiot. 1975, 28: 194 - 1f
Isaka M.Jaturapat A.Kramyu J.Tanticharoen M.Thebtaranonth Y. Antimicrob. Agents Chemother. 2002, 46: 1112 - 1g
Melvin MS.Calcutt MW.Noftle RE.Manderville RA. Chem. Res. Toxicol. 2002, 15: 742 - 1h
Melvin MS.Tomlinson JT.Park G.Day CS.Saluta GR.Kucera GL.Manderville RA. Chem. Res. Toxicol. 2002, 15: 734 - 1i
Melvin MS.Tomlinson JT.Saluta GR.Kucera GL.Lindquist N.Manderville RA. J. Am. Chem. Soc. 2000, 122: 6333 - 1j
Mortellaro A.Songia S.Gnocchi P.Ferrari P.Fornasiero C.D’Alessio R.Isetta A.Colotta F.Golay J. J. Immunol. 1999, 162: 7102 - 1k
Seganish JL.Davis JT. Chem. Commun. 2005, 5781 - 2
Fürstner A. Angew. Chem. Int. Ed. 2003, 42: 3582 - 3
Regourd J.Al-Sheikh Ali A.Thompson A. J. Med. Chem. 2007, 50: 1528 - 4
Sáez Díaz RI.Bennett SM.Thompson A. ChemMedChem 2009, 4: 742 - 5
Rapoport H.Holden KG. J. Am. Chem. Soc. 1962, 84: 635 - 6a
Boger DL.Patel M. J. Org. Chem. 1988, 53: 1405 - 6b
Wasserman HH.Lombardo L. Tetrahedron Lett. 1989, 30: 1725 - 6c
Wasserman HH.Petersen AK.Xia M.Wang J. Tetrahedron Lett. 1999, 40: 7587 - 7
D’Alessio R.Rossi A. Synlett 1996, 513 - 8
Dairi K.Tripathy S.Attardo G.Lavallee J. Tetrahedron Lett. 2006, 47: 2605 - 9a
Dairi K.Yao Y.Faley M.Tripathy S.Rioux E.Billot X.Rabouin D.Gonzalez G.Lavallee J.Attardo G. Org. Proc. Res. Dev. 2007, 11: 1051 - 9b
Pinkerton DM.Banwell MG.Willis AC. Org. Lett. 2007, 9: 5127 - 10
Clift MD.Thomson RJ. J. Am. Chem. Soc. 2009, 131: 14579 - 11
Sun LLC.Shirazian S.Zhou Y.Miller T.Cui J.Fukuda JY.Chu J.-Y.Nematalla A.Wang X.Chen H.Sistla A.Luu TC.Tang F.Wei J.Tang C. J. Med. Chem. 2003, 46: 1116 - 12a
Curti C.Sartori A.Battistini L.Rassu G.Burreddu P.Zanardi F.Casiraghi G. J. Org. Chem. 2008, 73: 5446 - 12b
Downey CW.Johnson MW. Tetrahedron Lett. 2007, 48: 3559 - 13
Brunings KJ.Corwin AH. J. Am. Chem. Soc. 1944, 66: 337 - 14
Rapoport H.Castagnoli N. J. Am. Chem. Soc. 1962, 84: 2178 - 15
Regourd J.Al-Sheikh Ali A.Thompson A. J. Med. Chem. 2007, 50: 1528 - 16
Wood TE.Ross AC.Dalgleish ND.Power ED.Thompson A.Chen X.Okamoto Y. J. Org. Chem. 2005, 70: 9967
References
- 1a
Baldino CM.Parr J.Wilson CJ.Ng S.Yohannes D.Wasserman HH. Bioorg. Med. Chem. Lett. 2006, 16: 701 - 1b
D’Alessio R.Bargiotti A.Carlini O.Colotta F.Ferrari M.Gnocchi P.Isetta A.Mongelli N.Motta P.Rossi A.Rossi M.Tibolla M.Vanotti E. J. Med. Chem. 2000, 43: 2557 - 1c
Davis JT.Gale PA.Okunola OA.Prados P.Iglesias-Sánchez JC.Torroba T.Quesada R. Nature Chem. 2009, 1: 138 - 1d
Diaz RIS.Regourd J.Santacroce PV.Davis JT.Jakeman DL.Thompson A. Chem. Commun. 2007, 2701 - 1e
Gerber NN. J. Antibiot. 1975, 28: 194 - 1f
Isaka M.Jaturapat A.Kramyu J.Tanticharoen M.Thebtaranonth Y. Antimicrob. Agents Chemother. 2002, 46: 1112 - 1g
Melvin MS.Calcutt MW.Noftle RE.Manderville RA. Chem. Res. Toxicol. 2002, 15: 742 - 1h
Melvin MS.Tomlinson JT.Park G.Day CS.Saluta GR.Kucera GL.Manderville RA. Chem. Res. Toxicol. 2002, 15: 734 - 1i
Melvin MS.Tomlinson JT.Saluta GR.Kucera GL.Lindquist N.Manderville RA. J. Am. Chem. Soc. 2000, 122: 6333 - 1j
Mortellaro A.Songia S.Gnocchi P.Ferrari P.Fornasiero C.D’Alessio R.Isetta A.Colotta F.Golay J. J. Immunol. 1999, 162: 7102 - 1k
Seganish JL.Davis JT. Chem. Commun. 2005, 5781 - 2
Fürstner A. Angew. Chem. Int. Ed. 2003, 42: 3582 - 3
Regourd J.Al-Sheikh Ali A.Thompson A. J. Med. Chem. 2007, 50: 1528 - 4
Sáez Díaz RI.Bennett SM.Thompson A. ChemMedChem 2009, 4: 742 - 5
Rapoport H.Holden KG. J. Am. Chem. Soc. 1962, 84: 635 - 6a
Boger DL.Patel M. J. Org. Chem. 1988, 53: 1405 - 6b
Wasserman HH.Lombardo L. Tetrahedron Lett. 1989, 30: 1725 - 6c
Wasserman HH.Petersen AK.Xia M.Wang J. Tetrahedron Lett. 1999, 40: 7587 - 7
D’Alessio R.Rossi A. Synlett 1996, 513 - 8
Dairi K.Tripathy S.Attardo G.Lavallee J. Tetrahedron Lett. 2006, 47: 2605 - 9a
Dairi K.Yao Y.Faley M.Tripathy S.Rioux E.Billot X.Rabouin D.Gonzalez G.Lavallee J.Attardo G. Org. Proc. Res. Dev. 2007, 11: 1051 - 9b
Pinkerton DM.Banwell MG.Willis AC. Org. Lett. 2007, 9: 5127 - 10
Clift MD.Thomson RJ. J. Am. Chem. Soc. 2009, 131: 14579 - 11
Sun LLC.Shirazian S.Zhou Y.Miller T.Cui J.Fukuda JY.Chu J.-Y.Nematalla A.Wang X.Chen H.Sistla A.Luu TC.Tang F.Wei J.Tang C. J. Med. Chem. 2003, 46: 1116 - 12a
Curti C.Sartori A.Battistini L.Rassu G.Burreddu P.Zanardi F.Casiraghi G. J. Org. Chem. 2008, 73: 5446 - 12b
Downey CW.Johnson MW. Tetrahedron Lett. 2007, 48: 3559 - 13
Brunings KJ.Corwin AH. J. Am. Chem. Soc. 1944, 66: 337 - 14
Rapoport H.Castagnoli N. J. Am. Chem. Soc. 1962, 84: 2178 - 15
Regourd J.Al-Sheikh Ali A.Thompson A. J. Med. Chem. 2007, 50: 1528 - 16
Wood TE.Ross AC.Dalgleish ND.Power ED.Thompson A.Chen X.Okamoto Y. J. Org. Chem. 2005, 70: 9967
References

Figure 1 C-Ring ester-functionalized prodigiosenes

Scheme 1 Synthetic strategies for the synthesis of prodigiosenes

Scheme 2 Preparation of ester-functionalized dipyrrinone analogues. a 4c was prepared using an esterification strategy (see Supporting Information for more details).

Figure 2 NOESY correlations observed for the dipyrrinones I and II

Figure 3 X-ray crystal structure of 6b

Figure 4 The symmetrical dipyrrin byproduct 8

Scheme 3 Preparation of ester-functionalized prodigiosenes

Scheme 4 Microwave-promoted transesterification of prodigiosene 1a